期刊文献+

2-硝基-1 H-咪唑甲酸乙酯衍生物的合成

Synthesis of Ethyl 2-Nitro-1 H-imidazolecar Boxylate Derivatives
下载PDF
导出
摘要 2-硝基咪唑是一种重要的医药中间体,可用于合成多种抗癌药物,通过对其结构进行修饰,有望开发新型活性药物分子。以2-氨基嘧啶和3-溴丙酮酸乙酯为起始原料,经过缩合环化、肼解、氧化和取代合成了一系列1-烷基-2-硝基-1 H-咪唑-5-甲酸乙酯(7a~7d)及其同分异构体1-烷基-2-硝基-1 H-咪唑-4-甲酸乙酯(8a~8d),该方法克服了传统合成路线中氮原子上取代基仅为甲基的局限性。研究不同取代基对2种异构体比例的影响,结果表明:随着取代基团的给电子能力增强,更加有利于化合物7的生成。所有合成化合物的结构都经过1 H NMR,13 C NMR和MS(ESI)确证或表征。 2-Nitroimidazole is an important pharmaceutical intermediate,which can be used to synthesize a variety of anticancer drugs.By modifying its structure,it is expected to develop new active drug molecules.In this paper,using 2-aminopyrimidine and ethyl 3-bromopyruvate as starting materials,a series of ethyl 1-alkyl-2-nitro-1 H-imidazole-5-carboxylates(7a~7d)and their isomers ethyl 1-alkyl-2-nitro-1 H-imidazole-4-carboxylates(8a~8d)were synthesized by the process of condensation cyclization,hydrazinolysis,oxidation,and substitution.This method overcame the limitation that the substituent on the nitrogen atom was only a methyl group in the traditional synthetic route.The effect of different substituents on the ratio of the two isomers was investigated,and the results showed that the formation of compounds 7 were more favorable as the electron-donating ability of the substituents increased.The structures of all synthesized compounds were confirmed or characterized by 1 H NMR,13 C NMR and MS(ESI)analyses.
作者 王顺 马鸿钊 陈夏彬 石靖 杨科 李正义 WANG Shun;MA Hongzhao;CHEN Xiabin;SHI Jing;YANG Ke;LI Zhengyi(Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology,School of Petrochemical Engineering,Changzhou University,Changzhou 213164,China;Jiangsu Huajing Molecular Imaging and Pharmaceutical Research Institute Co.,Ltd.,Changshu 215500,China)
出处 《合成化学》 CAS 2023年第12期956-961,共6页 Chinese Journal of Synthetic Chemistry
基金 江苏省先进催化与绿色制造协同创新中心资助项目。
关键词 2-硝基-1 H-咪唑甲酸乙酯 合成 同分异构体 电子效应 位阻效应 构效关系 医药中间体 ethyl 2-nitro-1 H-imidazolecarboxylate synthesis isomer electronic effect steric effect structure-activity relationship pharmaceutical intermediate
  • 相关文献

参考文献2

二级参考文献12

  • 1Kumar D, Tewari-Singh N, Agarwal C, et al. Nitro- gen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt- AP1 pathway leading to induction of inflammatory and proteolytic mediators [ J ]. Toxicology Letters, 2015,235 (3) :161 -171.
  • 2Gilkes D M, Semenza G L, Wirtz D. Hypoxia and the extracellular matrix : Drivers of tumour metastasis [ J ]. Nat Rev Cancer,2014,14(6) :430-439.
  • 3Yeh J J, Kim W Y. Targeting tumor hypoxia with hy- poxia-activated prodrugs[ J]. Journal of Clinical Oncol- ogy,2015,33(13) :1505 - 1508.
  • 4Liu Q, Sun J D, Wang J, et al. TH-302, a hypoxia- activated prodrug with broad in vivo preclinical combi- nation therapy efficacy: Optimization of dosing regi- mens and schedules [ J ]. Cancer Chemotherapy and Pharmacology,2012,69(6) : 1487 - 1498.
  • 5Borad M J, Reddy S G, Bahary N, et al. Ranomized phase II trial of gemcitabine plus TH-302 versus gemcit- abine in patients with advanced pancreatic cancer [ J ]. Journal of Clinical Oncology,2015,33(13) :1475 - 1482.
  • 6Goldman J, Belani C, Novello S, et al. Randomized, double-blind, placebo-controlled trim of evofosfamide (TH-302) in combination with pemetrexed in ad- vanced non-squamous non-small cell lung cancer[ J]. Annals of Oncology,2015,2fi( Suppl 1 ) :29 -44.
  • 7Sun J D, Meng F Y, Liu Q, et al. Association be- tween Chkl inhibitor AZD7762-mediated modulation of pharmacodynamic biomarkers and potentiation of hy-poxia-activated prodrug evofosfamide (TH-302) antitu- mor efficacy in a human tumor xenograft model [ M ]. San Francisco, American Association for Cancer Re- search, 2015.
  • 8http ://www. fiercebiotech.com/tags/threshold-pharmaceuticals.
  • 9Duan J, Jiao H, Kaierman J, et al. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs [ J ]. Journal of Medicinal Chemistry,2008,51 ( 8 ) :2412 - 2420.
  • 10Matteucci M,Duan J,Jiao H,et al.氨基磷酸酯烷化剂前体药物[P].CN200680030082.8,2009.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部